| __timestamp | Blueprint Medicines Corporation | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 242549000 |
| Thursday, January 1, 2015 | 48588000 | 245098000 |
| Friday, January 1, 2016 | 81131000 | 147600000 |
| Sunday, January 1, 2017 | 144687000 | 264600000 |
| Monday, January 1, 2018 | 243621000 | 357900000 |
| Tuesday, January 1, 2019 | 331450000 | 1182600000 |
| Wednesday, January 1, 2020 | 326860000 | 357700000 |
| Friday, January 1, 2021 | 601033000 | 540100000 |
| Saturday, January 1, 2022 | 477419000 | 322900000 |
| Sunday, January 1, 2023 | 427720000 | 408000000 |
| Monday, January 1, 2024 | 341433000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and Blueprint Medicines Corporation have demonstrated contrasting yet intriguing R&D investment strategies.
From 2014 to 2023, Blueprint Medicines Corporation increased its R&D expenses by over 1,200%, peaking in 2021 with a remarkable 601 million USD. This surge underscores their aggressive pursuit of groundbreaking therapies. Meanwhile, United Therapeutics Corporation, with a more stable trajectory, saw its highest R&D expenditure in 2019, reaching 1.18 billion USD, reflecting a strategic focus on sustained innovation.
These trends highlight the dynamic nature of R&D investments in the biotech sector, where strategic financial commitments can pave the way for future breakthroughs.
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Comparing Innovation Spending: United Therapeutics Corporation and Ultragenyx Pharmaceutical Inc.
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.